Efficacy and Safety of Recombinant Human Tumor Necrosis Factor Application for the Treatment of Mali

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：demon3214

【摘要】

：

目的： Malignant pleuraleffusion (MPE) is mainly caused by metastatic pleuralcancer and defines malignant tumors with apoor prognosis.To achieve sufficient control of MPE and to minimize invasive interve

【作者】

：

Qian Li Wenkui Sun Dongmei Yuan Tangfeng Lv Jie yin Ehong Cao Xinwu Xiao Yong Song

【机构】

：

Nanjing, China Jinling Hospital, School of Medicine Department of Respiratory and Critical Care Medi

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

Malignant pleural effusion Lung cancer

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

股前外侧皮瓣在头颈肿瘤术后缺损修复的应用

目的：目前大部分的恶性肿瘤的治疗仍以外科手术为主，肿瘤根治性切除后尤其是头颈部肿瘤术后的缺损，其外形及功能的修复重建是相当重要的。股前外侧皮瓣为我院最重要的修复手段。本文回顾性分析总结我院应用游离的股前外侧皮瓣在头颈肿瘤术后缺损修复和重建的临床应用经验。材料与方法：自2004年12月至2012年12月我院采用游离的股前外侧皮瓣修复重建头颈肿瘤术后缺损病例1023例。按照患者的疾病分类、缺损部位、重

会议

DIEP联合TRAM皮瓣在晚期乳腺癌术后复杂胸壁缺损修复的临床应用

目的：晚期乳腺癌特别是三阴患者，往往化疗不敏感，常常广泛侵犯皮肤或周围组织，部分有皮肤的溃烂流血，生活质量很差。为提高患者生活质量，减少肿瘤负荷，为术后的放疗化疗提供条件，行局部的扩大切除是很有必要的。但是该类手术常常导致胸壁广泛的缺损，修复非常困难。下腹部皮瓣为修复此类缺损的优良供区，但单蒂腹壁下动脉穿支(DIEP)或腹直肌(TRAM)的3区和4区常血供不足，而我们在修复如此巨大创面时又不能去掉

会议

The Status of Single Lung Lesion in Patients with History of Previous Malignancy: a Cross-sectional

Objective: Defining the status of single lung lesion and making treatment strategy was intricate, and had been well studied for decades.However, seldom studies had focused on this issue in patients wi

会议

single lung lesionprevious malignancystatus

XBP 1-LOX axis contributes to endoplasmic reticulum stress-induced growth of lung adenocarcinoma A54

Objective: Rapid growth of tumor cells needs to consume large amounts of oxygen and glucose, due to lack of blood supply within the tumor, cells live in an environment that lack of oxygen and nutrient

会议

3D cultureXBP1-LOXlung adenocarcinoma

Phase Ⅱ trial comparing tepotinib + gefitinib with cisplatin + pemetrexed in Asian patients with gef

Background: The combination of the highly selective c-Met inhibitor tepotinib (MSC2156119J) + gefitinib was shown to be well tolerated and have antitumor activity possibly associated with c-Met-positi

会议

NSCLC

淋巴结阳性局部进展期胃癌D2根治术后辅助放化疗获益人群筛选---N3病人能否从放化疗中获益?

目的：局部进展期胃癌(Locally advancedgastric cancer,LAGC)D2根治术后是否需要辅助放化疗(Chemoradiotherapy,CRT)目前仍存在争议.INT0116试验证明术后辅助放化疗优于单纯手术,然而ARTIST研究结果表明与术后辅助化疗(Chemotherapy,CT)相比,辅助放化疗并未带来生存获益.

会议

胃癌D2根治术辅助放化疗

Inhibiting autophagy promotes cisplatin-induced apoptotic cell death in A549 human lung cancer cells

Objective: Recent studies indicate that autophagy is adouble-edged sword in tumor genesis and plays an important role in theresistance of cancer cells to chemotherapy.We hypothesize that autophagy pro

会议

autophagyapoptosiscisplatin

Prognostic significance of survivin and thyroid transcription factor-1 in small cell lung cancer

Objective: Small cell lung cancer (SCLC) is a refractory subtype of lung cancer characterized by limited drug responses, aggressive metastasis and relapse at relatively earlystage when compared to non

会议

TTF-1survivinprognosis

口服甲苯磺酸多纳非尼片治疗晚期恶性实体肿瘤的ⅠA期耐受性和药代动力学研究

目的：甲苯磺酸多纳非尼是一种新开发的口服多激酶抑制剂类多靶点小分子抗肿瘤药物，可抑制VEGFR、PDGFR、Raf等多种受体激酶和其下游的Raf/MEK/ERK信号传导通路，达到抑制肿瘤细胞增殖和肿瘤血管新生的多重抗肿瘤作用。

会议

苯磺酸多纳非尼晚期实体瘤Ⅰ期研究

A single center, single arm and Phase Ⅱ clinical trail: the study of efficacy and safety of pulsatil

Objective: To observe the efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistanceto standard

会议

gefitiniberlotinibpulsatile administration

Efficacy and Safety of Recombinant Human Tumor Necrosis Factor Application for the Treatment of Mali

与本文相关的学术论文